Tag: Graft versus host disease

Introduction: Mesenchymal Stem Cells (MSCs) have emerged as a promising therapeutic option in Hematopoietic Stem Cell Transplantation (HSCT), particularly for addressing complications like Graft Versus Host Disease (GVHD) and Poor Graft Function (PGF). Their immunosuppressive, regenerative, and immunomodulatory properties make them a valuable addition to stem cell therapies. Visit https://www.stemcelltherjournal.org/jsctt for more groundbreaking research in…